Skip to main content
NeopharmCO.,LTD. logo

NeopharmCO.,LTD. — Investor Relations & Filings

Ticker · 092730 ISIN · KR7092730001 KO Manufacturing
Open in API
Filings indexed 205 across all filing types
Latest filing 2019-03-06 Proxy Solicitation & In…
Country KR South Korea
Listing KO 092730

About NeopharmCO.,LTD.

https://neopharm.co.kr

Neopharm is a science-based company specializing in the development, manufacturing, and sale of dermatological skincare and cosmetic products. A pioneer in skin barrier research, the company focuses on restoring skin homeostasis. Its core innovation is the proprietary Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin to repair and strengthen its protective functions. The company's primary product lines, including the flagship brand Atopalm, are specifically formulated for sensitive, dry, and compromised skin. These non-steroid solutions are grounded in dermatological science to address various skin concerns.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Neopharm. It contains the agenda for the upcoming annual general meeting, including financial statement approval, board appointments, and governance details. This type of document is specifically designed to provide shareholders with the necessary information to vote on matters at the meeting, which falls under the Proxy Solicitation & Information Statement category.
2019-03-06 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for NeoPharm. It outlines the date, location, agenda items (financial statements, dividend approval, board appointments), and details regarding director nominations. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of upcoming meeting details and agenda items for voting.
2019-03-05 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Neopharm regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the approval process via the upcoming general meeting of shareholders. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (NeoPharm) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for publicly traded companies in Korea (often referred to as a 'Fair Disclosure' or 'Earnings Release' equivalent in the local regulatory context). Since it provides key financial highlights (revenue, operating profit, net income) and the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2018
2019-02-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in NeoPharm (주)네오팜. This type of filing is a standard regulatory requirement in South Korea when an entity's shareholding crosses a specific threshold (typically 5%). It details the number of shares held, changes in ownership, and the purpose of the holding. This falls under the 'Major Shareholding Notification' category.
2019-01-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity acquires or changes a significant stake (typically 5% or more) in a listed company. This corresponds to the 'Major Shareholding Notification' category.
2018-12-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.